GLOBAL AMYOTROPHIC LATERAL SCLEROSIS (ALS) MARKET 2022 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Table of Contents

1 Market Overview
1.1 Amyotrophic Lateral Sclerosis (ALS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Amyotrophic Lateral Sclerosis (ALS) Market Size & Forecast
1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume (2017-2028)
1.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Price (2017-2028)
1.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity Analysis
1.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Total Production Capacity (2017-2028)
1.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Amyotrophic Lateral Sclerosis (ALS) Market Drivers
1.6.2 Amyotrophic Lateral Sclerosis (ALS) Market Restraints
1.6.3 Amyotrophic Lateral Sclerosis (ALS) Trends Analysis
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business
2.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan Pharma
2.3.1 Mylan Pharma Details
2.3.2 Mylan Pharma Major Business
2.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Glemark Generics
2.5.1 Glemark Generics Details
2.5.2 Glemark Generics Major Business
2.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Covis Pharma
2.6.1 Covis Pharma Details
2.6.2 Covis Pharma Major Business
2.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business
2.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lunan Pharma
2.8.1 Lunan Pharma Details
2.8.2 Lunan Pharma Major Business
2.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
2.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Amyotrophic Lateral Sclerosis (ALS) Breakdown Data by Manufacturer
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Amyotrophic Lateral Sclerosis (ALS)
3.4 Market Concentration Rate
3.4.1 Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2021
3.4.2 Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer Market Share in 2021
3.5 Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size by Region
4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2028)
4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2028)
4.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)
4.3 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)
4.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)
4.5 South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)
4.6 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Type (2017-2028)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
5.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Application (2017-2028)
6.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
6.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
7.2 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
7.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
7.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)
7.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
8.2 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
8.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
8.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
9.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
9.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Region
9.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
10.2 South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
10.3 South America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
10.3.1 South America Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)
10.3.2 South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
11.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
11.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
11.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Amyotrophic Lateral Sclerosis (ALS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Amyotrophic Lateral Sclerosis (ALS)
12.3 Amyotrophic Lateral Sclerosis (ALS) Production Process
12.4 Amyotrophic Lateral Sclerosis (ALS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Amyotrophic Lateral Sclerosis (ALS) Typical Distributors
13.3 Amyotrophic Lateral Sclerosis (ALS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Mitsubishi Tanabe Pharma Major Business
Table 5. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 6. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 10. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Pharma Major Business
Table 13. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 14. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Apotex Basic Information, Manufacturing Base and Competitors
Table 16. Apotex Major Business
Table 17. Apotex Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 18. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Glemark Generics Basic Information, Manufacturing Base and Competitors
Table 20. Glemark Generics Major Business
Table 21. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 22. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Covis Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Covis Pharma Major Business
Table 25. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 26. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Sun Pharma Major Business
Table 29. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 30. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Lunan Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Lunan Pharma Major Business
Table 33. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product and Services
Table 34. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 36. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Amyotrophic Lateral Sclerosis (ALS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Company, (K MT): 2020 VS 2021
Table 39. Head Office and Amyotrophic Lateral Sclerosis (ALS) Production Site of Key Manufacturer
Table 40. Amyotrophic Lateral Sclerosis (ALS) New Entrant and Capacity Expansion Plans
Table 41. Amyotrophic Lateral Sclerosis (ALS) Mergers & Acquisitions in the Past Five Years
Table 42. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)
Table 43. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)
Table 44. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 47. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 48. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2022) & (USD/MT)
Table 51. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2023-2028) & (USD/MT)
Table 52. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 53. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 54. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2022) & (USD/MT)
Table 57. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2023-2028) & (USD/MT)
Table 58. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 59. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 60. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 63. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 64. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 65. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 66. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 67. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 68. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 71. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 72. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 73. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 74. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)
Table 75. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)
Table 76. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 79. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 80. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 81. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 82. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 83. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 84. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 87. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 88. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 89. South America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 90. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)
Table 91. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)
Table 92. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 95. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 96. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 97. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 98. Amyotrophic Lateral Sclerosis (ALS) Raw Material
Table 99. Key Manufacturers of Amyotrophic Lateral Sclerosis (ALS) Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Amyotrophic Lateral Sclerosis (ALS) Typical Distributors
Table 103. Amyotrophic Lateral Sclerosis (ALS) Typical Customers
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Picture
Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type in 2021
Figure 3. Riluzole
Figure 4. Edaravone (Radicava)
Figure 5. Other
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Other
Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Sales (2017-2028) & (K MT)
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Price (2017-2028) & (USD/MT)
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity (2017-2028) & (K MT)
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Amyotrophic Lateral Sclerosis (ALS) Market Drivers
Figure 17. Amyotrophic Lateral Sclerosis (ALS) Market Restraints
Figure 18. Amyotrophic Lateral Sclerosis (ALS) Market Trends
Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturer in 2021
Figure 20. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Manufacturer in 2021
Figure 21. Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Amyotrophic Lateral Sclerosis (ALS) Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)
Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)
Figure 26. North America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)
Figure 27. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)
Figure 29. South America Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (USD Million)
Figure 31. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 32. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 33. Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2028) & (USD/MT)
Figure 34. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 35. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 36. Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2028) & (USD/MT)
Figure 37. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 38. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 39. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)
Figure 40. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)
Figure 41. United States Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 45. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 46. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)
Figure 47. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)
Figure 48. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)
Figure 57. China Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 64. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 65. South America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Country (2017-2028)
Figure 66. South America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Amyotrophic Lateral Sclerosis (ALS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis (ALS) in 2021
Figure 78. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis (ALS)
Figure 79. Amyotrophic Lateral Sclerosis (ALS) Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source